ClinicalTrials.govpublic full text
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
hepatocellular carcinoma, liver cancer, liver neoplasm, advanced hcc, hcc, metastatic liver cancer, car-t, cart, azd5851, t-cell, cell therapy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 910534
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.